Ozge Gumusay

5PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 09, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkers.

Bulent Cetin, Chiara A Wabl, Ozge Gumusay

|Jan 18, 2023
Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?

Bulent Cetin, Chiara A Wabl, Ozge Gumusay

|Feb 09, 2022
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer.

Bulent Cetin, Chiara A Wabl, Ozge Gumusay

|Jan 11, 2022
Immunotherapy toxicity: identification and management.

O Gumusay, J Callan, H S Rugo

|Nov 07, 2019
Contralateral Testicular Metastasis of Renal Cell Carcinoma: A Case Report.

Engin Kolukcu, Sahin Kilic, Bekir Süha Parlaktas

Pageof 1

Frequent Collaborators

3 joint publications

Bulent Cetin

3 joint publications

Chiara A Wabl

1 joint publications

Sahin Kilic

1 joint publications

Bekir Süha Parlaktas